THE FORSYTHE LITE LOW-DOSE CHEMO INSULIN POTENTIATED THERAPY (LDIPT) PROTOCOL

What this record means

The record shows that the mark “THE FORSYTHE LITE LOW-DOSE CHEMO INSULIN POTENTIATED THERAPY (LDIPT) PROTOCOL” was registered on the Principal Register in May 2015 but was cancelled in November 2021 because the owner, James W. M. Forsythe, did not file a Section 8 declaration. The mark covers a narrow set of medical and beauty services, specifically alternative medicine, consulting, diagnosis, and treatment services for cancer, including integrative oncology and homeopathic treatment. A similar name would raise the closest concern if used for comparable cancer‑related medical services, especially those involving alternative or integrative approaches. The record does not give the owner control over every use of the wording; it is limited to the listed services. The prosecution history shows a typical sequence of examination, amendment, and publication, with no indication that the mark was ever moved to the Supplemental Register. The latest status event is the cancellation in November 2021, and no enforcement actions are recorded. For someone considering a similar name, the cancelled status reduces the risk, but the specific cancer‑treatment services listed remain a potential point of concern.